发明公开
EP2387565A2 2,4-PYRIMIDINEDIAMINE COMPOUNDS FOR TREATMENT OF INFLAMMATORY DISORDERS
有权
2.4 PYRIMIDINDIAMINVERBINDUNGEN炎症性疾病的治疗
- 专利标题: 2,4-PYRIMIDINEDIAMINE COMPOUNDS FOR TREATMENT OF INFLAMMATORY DISORDERS
- 专利标题(中): 2.4 PYRIMIDINDIAMINVERBINDUNGEN炎症性疾病的治疗
-
申请号: EP10732053.3申请日: 2010-01-13
-
公开(公告)号: EP2387565A2公开(公告)日: 2011-11-23
- 发明人: GURURAJA, Tarikere , PAYAN, Donald , TSO, Kin , KINOSHITA, Taisei , DING, Rongxian , SINGH, Rajinder , YUNG, Stephanie , LI, Hui , MASUDA, Esteban
- 申请人: Rigel Pharmaceuticals, Inc.
- 申请人地址: 1180 Veterans Boulevard South San Francisco, CA 94080 US
- 专利权人: Rigel Pharmaceuticals, Inc.
- 当前专利权人: Rigel Pharmaceuticals, Inc.
- 当前专利权人地址: 1180 Veterans Boulevard South San Francisco, CA 94080 US
- 代理机构: Wytenburg, Wilhelmus Johannes
- 优先权: US144616P 20090114
- 国际公布: WO2010083241 20100722
- 主分类号: C07D239/32
- IPC分类号: C07D239/32 ; C07D239/30 ; C07D403/12 ; A61K31/495 ; A61P29/00
摘要:
2,4-Pyrimidinediamine compounds represented by formula (I), methods for preparing the same and methods for treating an inflammatory disorder and for inhibiting the production of IL-23 and/or stimulating the production of IL-10 using the same are disclosed.
公开/授权文献
信息查询